The cost of immunotherapy in Spain typically ranges from $12,000 to $25,000. Prices vary depending on the type of immunotherapy used (such as monoclonal antibodies, checkpoint inhibitors, or CAR-T cell therapy), the number of treatment cycles, the clinic, and the treating physician’s expertise. In the United States, the average price is $30,000 (according to the American Cancer Society). This means immunotherapy in Spain can be about 38% less than in the U.S.
Spanish clinics usually include initial consultation, diagnostic tests, medication administration, monitoring during treatment, and scheduled follow-up visits in the overall cost. In the U.S., the listed price often covers only the medication, with separate charges for doctor’s visits, lab tests, and infusion services. Always confirm exactly what’s included at each clinic.
Why choose Spain for immunotherapy?
Access advanced Immunotherapy solutions in trusted clinics .
| Turchia | Austria | Spain | |
| Immunotherapy | da $2,200 | da $30,000 | da $12,000 |
| Sarcoma Immunotherapy | da $18,000 | da $60,000 | da $80,000 |
| Immunotherapy for prostate cancer | da $12,000 | da $30,000 | da $35,000 |
| Immunotherapy for lung cancer | da $18,000 | da $30,000 | da $30,000 |
| Immunotherapy for breast cancer | da $9,500 | da $35,000 | da $45,000 |
Revisionato medicalmente da
Fahad MawloodBookimed non aggiunge costi extra ai prezzi di Immunotherapy. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Immunotherapy al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Immunotherapy e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Immunotherapy.
Dr. Graupera heads the Hematology Oncology Department at Sant Joan De Déu – one of Europe's top children's hospitals. His research focuses on pediatric cancer treatments.
Dr. Graus defined the first strict diagnostic criteria for paraneoplastic neurological syndromes – a key breakthrough in immunotherapy-related neurotoxicity.
Leader in immunotherapy research for melanoma and breast cancer – Dr. Soberino has contributed to groundbreaking drug approvals that revolutionized treatment.
World-renowned leader in Chronic Lymphocytic Leukemia (CLL) – Professor Bosch leads over 80 clinical trials on new treatments.